Shi Ding

428 total citations
38 papers, 339 citations indexed

About

Shi Ding is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shi Ding has authored 38 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 15 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Shi Ding's work include Synthesis and biological activity (8 papers), Cancer Mechanisms and Therapy (7 papers) and Ruminant Nutrition and Digestive Physiology (6 papers). Shi Ding is often cited by papers focused on Synthesis and biological activity (8 papers), Cancer Mechanisms and Therapy (7 papers) and Ruminant Nutrition and Digestive Physiology (6 papers). Shi Ding collaborates with scholars based in China, Canada and Australia. Shi Ding's co-authors include Ye Chen, Yushe Yang, Wen‐Jing Chu, Tim A. McAllister, Alex V. Chaves, Yunlei Hou, Ju Liu, Sarah J. Meale, Yajing Liu and R. D. Bush and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and Journal of Animal Science.

In The Last Decade

Shi Ding

37 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi Ding China 11 153 122 50 37 35 38 339
Sajid Khan Tahir Pakistan 8 64 0.4× 163 1.3× 8 0.2× 76 2.1× 18 0.5× 34 316
Yonghui Wang China 13 26 0.2× 320 2.6× 9 0.2× 44 1.2× 13 0.4× 22 425
Lin Su China 12 101 0.7× 224 1.8× 2 0.0× 34 0.9× 29 0.8× 33 525
Yuya Wang China 10 17 0.1× 165 1.4× 7 0.1× 51 1.4× 25 0.7× 39 401
Joseph Shaw United Kingdom 6 13 0.1× 120 1.0× 38 0.8× 24 0.6× 25 0.7× 13 214
Bojing Zhu China 12 66 0.4× 395 3.2× 3 0.1× 41 1.1× 23 0.7× 26 541
Wenliang Qiao China 12 48 0.3× 273 2.2× 3 0.1× 163 4.4× 123 3.5× 21 534
Tianran Ma China 11 50 0.3× 279 2.3× 5 0.1× 41 1.1× 10 0.3× 21 343
Hao Wei China 10 33 0.2× 156 1.3× 4 0.1× 32 0.9× 17 0.5× 15 327

Countries citing papers authored by Shi Ding

Since Specialization
Citations

This map shows the geographic impact of Shi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Ding more than expected).

Fields of papers citing papers by Shi Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Ding. The network helps show where Shi Ding may publish in the future.

Co-authorship network of co-authors of Shi Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Ding. A scholar is included among the top collaborators of Shi Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Ding. Shi Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cao, Xuefeng, Liang Zhao, Jian Zhou, et al.. (2025). Dexmedetomidine inhibits ferroptosis through the Akt/GSK3β/Nrf2 axis and alleviates adriamycin-induced cardiotoxicity. Life Sciences. 371. 123609–123609. 2 indexed citations
3.
Ru, Qin, Bing Ma, Min Yuan, et al.. (2025). Structural characteristics and SARs of EZH2 inhibitors. Molecular Diversity. 1 indexed citations
4.
Wu, Shuang, et al.. (2024). Recent advances in c-Met-based dual inhibitors in the treatment of cancers. European Journal of Medicinal Chemistry. 272. 116477–116477. 13 indexed citations
5.
Zhang, Yadong, Wen Di, Jiwei Shen, et al.. (2023). Application and SARs of Pyrazolo[1,5-a]pyrimidine as Antitumor AgentsScaffold. Current Topics in Medicinal Chemistry. 23(12). 1043–1064. 2 indexed citations
6.
Shen, Jiwei, Jiawei Li, Zhi Wang, et al.. (2023). Design, synthesis, and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives as potent antitumor agents. New Journal of Chemistry. 47(46). 21318–21331. 4 indexed citations
7.
Ding, Shi, Rui Qi, Mingjuan Zhang, et al.. (2022). Design, synthesis and biological evaluation of novel osimertinib derivatives as reversible EGFR kinase inhibitors. European Journal of Medicinal Chemistry. 238. 114492–114492. 17 indexed citations
8.
9.
Ding, Shi, Mingjuan Zhang, Fang Liu, et al.. (2021). Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors. Bioorganic Chemistry. 118. 105471–105471. 13 indexed citations
10.
Zhao, Xinghua, et al.. (2021). Pharmacokinetics study of potential anti-CML drug Cyclobentinib (CB1107) by HPLC–MS/MS. 3(1). 169–175. 1 indexed citations
11.
Wei, Hao, Zhen Li, Fang Liu, et al.. (2021). The Role of FTO in Tumors and Its Research Progress. Current Medicinal Chemistry. 29(5). 924–933. 15 indexed citations
12.
Wang, Yang, et al.. (2020). Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors. European Journal of Medicinal Chemistry. 194. 112244–112244. 42 indexed citations
13.
Zhao, Xinghua, et al.. (2020). Advances in Drug Therapy for Systemic Lupus Erythematosus. Current Medicinal Chemistry. 28(6). 1251–1268. 4 indexed citations
14.
Wang, Zhen, Wenwen Zhao, Yunlei Hou, et al.. (2020). Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors. Bioorganic Chemistry. 105. 104371–104371. 17 indexed citations
15.
Ding, Shi, et al.. (2020). Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors. Anti-Cancer Agents in Medicinal Chemistry. 20(5). 559–570. 1 indexed citations
16.
Liang, Yutong, Xinghua Zhao, Ming Wang, et al.. (2020). Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis. Current Drug Delivery. 18(3). 357–368. 8 indexed citations
17.
Chen, Ye, et al.. (2019). Synthesis, Crystal Structure, and Antiproliferative Activity of Novel 7-Arylaminopyrazolo[1,5-a]pyrimidine Derivatives Containing the Hydrazone Moiety. Russian Journal of General Chemistry. 89(11). 2321–2327. 3 indexed citations
18.
Ding, Shi, Wenke Wang, Qiao Cao, et al.. (2017). Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 28(2). 94–102. 13 indexed citations
19.
Ding, Shi, et al.. (2015). Synthesis and structure–activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 25(10). 2203–2210. 14 indexed citations
20.
Meale, Sarah J., Shi Ding, Ming‐Liang He, et al.. (2014). Effect ofPropionibacterium freudenreichiion ruminal fermentation patterns, methane production and lipid biohydrogenation of beef finishing diets containing flaxseed oil in a rumen simulation technique. Canadian Journal of Animal Science. 94(4). 685–695. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sajid Khan Tahir Breakdown of academic impact, for papers by Yonghui Wang Breakdown of academic impact, for papers by Lin Su Breakdown of academic impact, for papers by Yuya Wang Breakdown of academic impact, for papers by Joseph Shaw Breakdown of academic impact, for papers by Bojing Zhu Breakdown of academic impact, for papers by Wenliang Qiao Breakdown of academic impact, for papers by Tianran Ma Breakdown of academic impact, for papers by Hao Wei
Rankless by CCL
2026